More News of Interest

InVivo Therapeutics Announces New Patient Enrollment into The INSPIRE Study at Thomas Jefferson University Hospital

InVivo Therapeutics Holdings Corp. (NVIV) today announced that a new patient has been enrolled into The INSPIRE Study (InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold™ for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury) at Thomas Jefferson University Hospital in Philadelphia, PA. James Harrop, M.D., Professor of Neurological and Orthopedic Surgery, Co-Director at the Delaware Valley Spinal Cord Injury Center, and Principal Investigator at the site, and Josh Heller, M.D., successfully performed the surgery and implantation approximately 22 hours after the injury occurred.

Dr. Harrop said, “The surgery and implantation went smoothly and the patient is recovering well. We are excited to be part of The INSPIRE Study and we look forward to following and communicating the patient’s progress.”

Chief Executive Officer and Chairman Mark Perrin said, “We are pleased to hear that the patient is doing well. We now have 17 patients enrolled and in follow up, and with this patient marking the second enrollment in the last week, we remain enthusiastic about completing INSPIRE enrollment during the third quarter of this year.”

Latest Posts

Don't Miss